Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr712 Inhibitors

Olr712 inhibitors represent a fascinating and specialized category of chemical compounds known for their ability to modulate the activity of the Olr712 receptor, a member of the olfactory receptor family. Olfactory receptors are G protein-coupled receptors (GPCRs) predominantly expressed in the sensory neurons of the olfactory epithelium, where they play a crucial role in the detection of odorants. However, research has identified the presence of olfactory receptors, including Olr712, in non-olfactory tissues, where they may be involved in various cellular processes. Olr712 inhibitors are designed to specifically bind to the Olr712 receptor, preventing its activation by endogenous ligands. The chemical structures of these inhibitors vary widely, but they typically feature moieties capable of interacting with the binding site of Olr712 through non-covalent interactions such as hydrogen bonding, van der Waals forces, and hydrophobic interactions.

The development of Olr712 inhibitors involves extensive structure-activity relationship (SAR) studies to optimize their selectivity and potency. This process often includes high-throughput screening of large chemical libraries, followed by iterative cycles of chemical synthesis and biological evaluation. The primary goal is to identify compounds that exhibit high affinity for Olr712 while minimizing off-target effects on other olfactory receptors or GPCRs. Once lead compounds are identified, further optimization may include modifications to improve their pharmacokinetic properties, such as stability, solubility, and membrane permeability. Analytical techniques such as X-ray crystallography and molecular modeling are employed to elucidate the binding interactions at the molecular level, providing insights into the design of more effective inhibitors. These inhibitors serve as valuable tools for probing the physiological and biochemical functions of the Olr712 receptor in various cellular contexts, enhancing our understanding of olfactory receptor signaling pathways and their broader biological roles.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

RAF kinase inhibitor, potentially affecting proteins in RAF/MEK/ERK signaling pathways.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$117.00
$423.00
11
(1)

BRAF kinase inhibitor, potentially disrupting proteins in the MAPK/ERK pathway.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

EGFR tyrosine kinase inhibitor, potentially affecting proteins in the EGFR signaling pathway.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

BCR-ABL tyrosine kinase inhibitor, potentially affecting proteins in leukemia signaling pathways.

Tamoxifen

10540-29-1sc-208414
2.5 g
$272.00
18
(2)

Selective estrogen receptor modulator, potentially influencing proteins in estrogen receptor signaling pathways.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

BCR-ABL tyrosine kinase inhibitor, potentially affecting proteins in leukemia signaling pathways.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Bruton's tyrosine kinase inhibitor, potentially impacting proteins in B-cell receptor signaling pathways.